More Clinical Articles

Clinical

More Approvals for Neglected Diseases but not R&D

Anonymous, (Jul 15, 2013)

Annual R&D spending for neglected diseases has been static since 2007 even though new research suggests that yearly approvals in this illness area have doubled in recent years.
Clinical

Pfizer Continues Investment In Ireland

Lucy Brake, (Jul 15, 2013)

To support the development of new pharmaceuticals in Pfizer’s pipeline, the US company is investing US$130 million into Irish plants.
Clinical

Nearly $8 Billion Profit Expected in NSCLC Market due to B-MS Blockbuster

Anonymous, (Jul 10, 2013)

Bristol Myers-Squibb’s (B-MS) nivolumab could expand the global non-small cancer cell lung cancer (NSCLC) market from $5.7 billion in 2012 to $7.9 billion in 2022.
Clinical

New UK DNA Mapping Project Targets Cancer, Rare Diseases And Infectious Diseases

Lucy Brake, (Jul 9, 2013)

UK Health Secretary Jeremy Hunt has announced that the UK’s new DNA mapping project will focus its genetic analysis efforts on lung and children's cancer, rare diseases and infectious diseases.
Clinical

Two Patients Remain HIV Free After Bone Marrow Transplant

Zuzanna Fimińska, (Jul 5, 2013)

Two HIV-positive patients who received bone marrow transplants to cure leukemia appear virus-free despite stopping treatment with antivirals, the researchers from the Brigham and Women’s Hospital in Boston announced Wednesday.
Clinical

Improved Biotech Growth could also Encourage Further M&A Deals

Anonymous, (Jul 2, 2013)

A report indicating an expected £7.8 billion in revenue during 2013/2014 for the UK biotechnology industry could also signal the continued growth of pharmaceutical M&A deals.
Clinical

Big Pharma Outsources Innovation

Louise Kelly, (Jun 25, 2013)

As the pharmaceutical industry continues its never-ending quest to discover new medicines, licensing agreements with smaller market players are becoming more popular than ever.
Clinical

Total Access: YODA Gains Full Access to Clinical Trials Data

Zuzanna Fimińska, (Jun 19, 2013)

The Yale University Open Data project (YODA) have been given total access to all patient-level data from trials on recombinant human bone morphogenetic protein 2 (rhBMP-2), in the first move towards a full and frank disclosure of data.
Clinical

Online Networks Like PatientsLikeMe Could be the Key to Clinical Trial Recruitment

Anonymous, (Jun 19, 2013)

New partnership between PatientsLikeMe and inVentiv Health demonstrates the expanding role of digital networks in lowering the cost of clinical trial recruitment.
Clinical

AstraZeneca gets Full Marks for Growth Strategy

Louise Kelly, (Jun 18, 2013)

AstraZeneca solidifies its links with academics and the scholarly elite as it signs two R&D deals with Cancer Research UK and the University of Manchester – and announces its plans to relocate its HQ to Cambridge.

Pages